Cancer hallmarks in induced pluripotent cells: New insights

Journal of Cellular Physiology

Volumn 225, Issue 2, 2010, Pages 390-393

  Malchenko, Sergey ^a   Galat, Vasiliy ^a   Seftor, Elisabeth A ^a   Vanin, Elio F ^a   Costa, Fabricio F ^a   Seftor, Richard E B ^a   Soares, Marcelo B ^a   Hendrix, Mary J C ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEFT RIGHT DETERMINATION FACTOR; MICRORNA; NODAL SIGNALING PROTEIN; TRANSFORMING GROWTH FACTOR BETA; MESSENGER RNA; TUMOR MARKER;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CPG ISLAND; EMBRYO; EMBRYONIC STEM CELL; EPIGENETICS; HUMAN; HUMAN CELL; METHYLATION; NEOPLASM; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; CELL LINE; CYTOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BLOTTING, WESTERN; CELL LINE; EMBRYONIC STEM CELLS; EPIGENESIS, GENETIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; PLURIPOTENT STEM CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 77956498656     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22280     Document Type: Article

References (20)

1. Chin MH, Mason MJ, XieW, Volinia S, Singer M, Peterson C, Ambartsumyan G, Aimiuwu O, Richter L, Zhang J, Khvorostov I, Ott V, Grunstein M, Lavon N, Benvenisty N, Croce CM, Clark AT, Baxter T, Pyle AD, Teitell MA, Pelegrini M, Plath K, Lowry WE. 2009. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 5:111-123.
2. Costa FF, Seftor EA, Bischof JM, Kirschmann DA, Strizzi L, Arndt K, de Fatima Bonaldo M, Soares MB, Hendrix MJC. 2009. Epigenetically reprogramming metastatic tumor cells with an embryonic microenvironment. Epigenomics 1:387-398.
3. Doi A, Park IH, Wen B, Murakami P, Aryee MJ, Irizarry R, Herb B, Ladd-Acosta C, Rho J, Loewer S, Miller J, Schlaeger T, Daley GQ, Feinberg AP. 2009. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet 41:1350-13533.
4. Feng Q, Lu SJ, Klimanskaya I, Gomes I, Kim D, Chung Y, Honig GR, Kim KS, Lanza R. 2010. Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. Stem Cells 28:704-712.
5. Gibcus JH, Tan LP, Harms G, Schakel RN, de Jong D, Blokzijl T, Möller P, Poppema S, Kroesen BJ, van den Berg A. 2009. Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile. Neoplasia 11:167-176.
6. Greither T, Grochola LF, Udelnow A, Lautenschläger C, Würl P, Taubert H. 2010. Elevated expression of microRNAs 155, 203 210 and 222 in pancreatic tumors is associated with poorer survival. Int J Cancer 126:73-80.
7. Knoepfler PS. 2009. Deconstructing stem cell tumorigenicity: A roadmap to safe regenerative medicine. Stem Cells 27:1050-1056.
8. Laurent LC, Nievergelt CM, Lynch C, Fakunle E, Harness JV, Schmidt U, Galat V, Laslett AL, Otonkoski T, Keirstead HS, Schork A, Park HS, Loring JF. 2010. Restricted ethnic diversity in human embryonic stem cell lines. Nat Methods 7:6-7.
9. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408.
10. Mertens-Talcott SU, Chintharlapalli S, Li X, Safe S. 2007. The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. Cancer Res 67:11001-11011. (Pubitemid 350145930)
11. Okita K, Ichisaka T, Yamanaka S. 2007. Generation of germline-competent induced pluripotent stem cells. Nature 448:313-317. (Pubitemid 47080336)
12. Pichiorri F, Suh SS, Ladetto M, Kuehl M, Palumbo T, Drandi D, Taccioli C, Zanesi N, Alder H, Hagan JP, Munker R, Volinia S, Boccadoro M, Garzon R, Palumbo A, Aqeilan RI, Croce CM. 2008. MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. Proc Natl Acad Sci USA 105:12885-12890.
13. Postovit LM, Margaryan NV, Seftor EA, Kirschmann DA, Lipavsky A, Wheaton WW, Abbott DE, Seftor RE, Hendrix MJ. 2008. Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells. Proc Natl Acad Sci USA 105:4329-4334. (Pubitemid 351754380)
14. Schier AF. 2003. Nodal signaling in vertebrate development. Annu Rev Cell Dev Biol 19:589-621.
15. Schier AF, Shen MM. 2000. Nodal signaling in vertebrate development. Nature 403:385-389.
16. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. 1998. Embryonic stem cell lines derived from human blastocysts. Science 282:1145-1147. Erratum in: Science 282 (5395):1827, 1998.
17. Tong AW, Fulgham P, Jay C, Chen P, Khalil I, Liu S, Senzer N, Eklund AC, Han J, Nemunaitis J. 2009. MicroRNA profile analysis of human prostate cancers. Cancer Gene Ther 16:206-216.
18. Wernig M, Meissner A, Cassady JP, Jaenisch R. 2008. c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2:10-12.
19. Yan LX, Huang XF, Shao Q, Huang MY, Deng L, Wu QL, Zeng YX, Shao JY. 2008. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 14:2348-2360.
20. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA. 2007. Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917-1920.